Cellzome GmbH, a GSK company

Cellzome is a world leader in chemoproteomics, transforming the sciences of epigenetics and signal transduction into novel drug candidates in inflammatory diseases and oncology. The Company maintains the highest levels of scientific expertise and has active collaborations with the foremost academic laboratories around the world. Cellzome's technologies work with native proteins in a physiological setting to discover small molecule drugs targeting protein complexes that underlie diseases. The Company has a track record in delivering significant collaborations with top pharmaceutical companies including GlaxoSmithKline, Johnson & Johnson and Novartis. Cellzome is a privately-held, international, company located in Heidelberg, Germany and Cambridge, UK employing about 100 people, of which 65% are women. *

	Start	2012-09-14 reorganised
	Group	GSK (Group)
	Predecessor	Cellzome AG
	Industry	proteomics

	Region	Heidelberg
	Country	Germany
	Street	1 Meyerhofstr.
	City	69117 Heidelberg
	Tel	+49-6221-13570
		Address record changed: 2021-10-30

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2024-12-29

Picture Kenes Exhibitions Biomed Israel 2025 Tel Aviv 650x200px

More documents for GSK (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com